| Dr Michael Andre Lenoir, MD | |
|
3448 Mowry Ave, Fremont, CA 94538-1422 | |
| (510) 373-3000 | |
| (844) 965-9795 |
| Full Name | Dr Michael Andre Lenoir |
|---|---|
| Gender | Male |
| Speciality | Allergy & Immunology - Allergy |
| Location | 3448 Mowry Ave, Fremont, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023065760 | NPI | - | NPPES |
| OOC13360 | Medicaid | CA |
| Entity Name | Comprehensive Allergy Service Medical Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770539041 PECOS PAC ID: 2264651363 Enrollment ID: O20140923001666 |
News Archive
A study of patients with implantable cardiac devices such as pacemakers, implantable defibrillators or left ventricular assist devices found that performing capsule endoscopy in these patients is safe and that the devices in general do not interfere with images captured by the capsule.
Quantifying tablet disintegration profiles in situ and in real time enables scientists to reliably understand the breakage and dispersion mechanisms that govern API release rates. This essential process knowledge can support the prediction of in vivo drug release profiles during formulation development, and help identify the root cause of inconsistencies during release testing.
Mustafa al'Absi, Ph.D., professor of behavioral sciences at the University of Minnesota Medical School - Duluth Campus, and director of the Duluth Medical Research Institute, has received funding and launched a new first-of-its-kind international research initiative: "Khat Research Program: Neurobehavioral Impact of Long-Term Use".
Malaria deaths reported from health facilities in Zambia have declined by 66%. This result along with other supporting data indicates that Zambia has reached the 2010 Roll Back Malaria target of a more than 50% reduction in malaria mortality compared to 2000.
An international, multicenter phase II clinical trial is evaluating the efficacy and safety of mavrilimumab co-administered with a 26-week corticosteroid taper in patients with giant cell arteritis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Andre Lenoir, MD 7677 Oakport St Ste 105, Oakland, CA 94621-1961 Ph: (510) 993-0200 | Dr Michael Andre Lenoir, MD 3448 Mowry Ave, Fremont, CA 94538-1422 Ph: (510) 373-3000 |
News Archive
A study of patients with implantable cardiac devices such as pacemakers, implantable defibrillators or left ventricular assist devices found that performing capsule endoscopy in these patients is safe and that the devices in general do not interfere with images captured by the capsule.
Quantifying tablet disintegration profiles in situ and in real time enables scientists to reliably understand the breakage and dispersion mechanisms that govern API release rates. This essential process knowledge can support the prediction of in vivo drug release profiles during formulation development, and help identify the root cause of inconsistencies during release testing.
Mustafa al'Absi, Ph.D., professor of behavioral sciences at the University of Minnesota Medical School - Duluth Campus, and director of the Duluth Medical Research Institute, has received funding and launched a new first-of-its-kind international research initiative: "Khat Research Program: Neurobehavioral Impact of Long-Term Use".
Malaria deaths reported from health facilities in Zambia have declined by 66%. This result along with other supporting data indicates that Zambia has reached the 2010 Roll Back Malaria target of a more than 50% reduction in malaria mortality compared to 2000.
An international, multicenter phase II clinical trial is evaluating the efficacy and safety of mavrilimumab co-administered with a 26-week corticosteroid taper in patients with giant cell arteritis.
› Verified 6 days ago
Randolph Lippert, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000 | |
Dr. Rao R Kosaraju, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1999 Mowry Ave, Suite L, Fremont, CA 94538 Phone: 510-373-3000 Fax: 510-744-9959 | |
Grace Yu, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 3200 Kearney Street, Fremont, CA 94301 Phone: 510-490-1222 | |
Chyh Woei Lee, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3200 Kearney St, Fremont, CA 94538 Phone: 510-498-2350 | |
Kristina Philpott, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3200 Kearney St., Fremont, CA 94538 Phone: 510-490-1222 |